Alex Brill and Angela Banks Dive into the Critical Need for Competition, Big Drug Companies’ Abuse of the Patent System, and Biosimilar Adoption In case you missed it, Angela Banks, Vice President of Policy for the Pharmaceutical Care Management Association
As the debate on high-cost prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign OnYourRxSide. The campaign is designed
May is Asthma Awareness Month, and today – May 5 – is World Asthma Day. The Asthma and Allergy Foundation of America is marking the day with the release of their 2021 Asthma Capitals Report.
The Value of Pharmacy Benefit Management PBMs Create $145 Billion in Value Annually Groundbreaking research by University of Chicago Economics Professor Casey Mulligan describes the services that pharmacy benefit managers (PBMs) provide in the healthcare marketplace to patients, health plans,
(Washington, D.C.) —The Pharmaceutical Care Management Association (PCMA) is launching a new print and digital ad campaign – “Protect the Savings” – to defend the savings that pharmacy benefit managers (PBMs) negotiate from drugmakers, and warn against the Administration’s newly
(Washington, D.C.) — A new white paper, “Solving America’s High Drug Cost Problem: Prevent Drug Company Tactics that Increase Costs and Undermine Clinical Quality,” by the Pharmacy Benefit Management Institute (PBMI), released today by the Pharmaceutical Care Management Association (PCMA),
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on passage of prescription drug legislation in New Jersey. “PCMA applauds the New Jersey Assembly for passing S2690 / A3993 / A 2214, legislation that will help ensure New
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA), today, is announcing a new ad campaign, “Drug Manufacturers are Pointing Fingers…Again.” With Congress poised to permanently repeal the rebate rule and prevent significant increases in both Medicare beneficiary premiums and Medicare
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new report, “Drug Manufacturer Strategies for Keeping Drug Costs High,” on pharmaceutical industry pricing tactics that increase prescription drug costs for patients. The report, conducted by the research firm Visante,
©2024 PCMA. All Rights Reserved.
